The analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 7.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 7%. Our forward projection puts the odds of a 10% gain over the next month near 36%. The street (1 analysts) rates it strong buy, with a mean price target of $7.
Vizsla Silver Corp.
VZLA · NYSE American · USD · Market cap $1.1B · 79 employees
Vizsla Silver Corp.
FAIL · Does not pass the screenPrice as of 13 Nov 2026Daily close, not a live quote
Screened 2026-11-13 · the tape above runs as of 08:09 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed
Key facts today
- Price3.07 USD at the 13 Nov 2026 close
- Fair valueUnder review: only one analyst covers it, too few to cross-check it; our model's value is 2.02x the price, above our 1.35x limit.
- Our regime readDistribution, as of 15 Nov 2026
- Ethical screenDoes not pass
- OptionsOpen interest leans to puts (put/call 1.14)
- Last reviewed13 Nov 2026 (3 days ago)
- Release timesRelease and earnings times on your chart: Event Guard Mentor
A summary of the dated readings below, not a live quote and not advice.
Our fair-value range: range not available (screen dated 2026-11-13).
- Trend Distribution
- Insiders no filings inside 60 days, left as found
- Positioning no disclosures inside 60 days, left as found
- Options put/call open interest 1.14, read 2026-11-14
- Ethical does not pass the values gate
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
This name holds its distribution label.
Vizsla Silver Corp. holds its Distribution at $3.07. Consolidating, no directional conviction, held for 62 days.
| Phase | Distribution · caution |
| Quantitative state | Consolidating, no directional conviction, held for 62 days |
| Price at the screen | $3.07 |
| Valuation | N/A trailing · N/A forward price to earnings |
| Values screen | FAIL · score 70.0 |
| Beta | 1.57 |
Five Screens, Shown in Full
Does not pass. Accounts receivable
| Test | Figure | Limit | What it means | Status |
|---|---|---|---|---|
| Business activity | Permissible | Core business clean | Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending. | Pass |
| Debt load | 32.45% | Below 33% | Interest-bearing debt is just 32.4% of its assets, well under the one-third ceiling: it does not run on borrowed money. | Pass |
| Interest-bearing cash | 0.50% | Below 33% | Cash held in interest-bearing accounts and securities is 0.5% of assets, under the one-third limit. | Pass |
| Receivables | 58.62% | Below 49% | Money owed to the company is 58.6% of assets, above the 49% limit. | Fail |
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
The Ethical ReadWhy It Falls Short, in Plain English
Vizsla Silver's business is fine, but its receivables are about 59% of its assets, just over the ~49% line, so it does not pass on the financial screens.
Read as at 2026-11-15. It updates when the underlying figures move, and past reads are kept below.
Follow this verdict
Get an email when VZLA's ethical verdict changes
Today VZLA does not pass the screen. If new figures move it to a pass, we send you one short email with the before and after. Verdicts change rarely, so you may not hear from us for a long time.
Free, no account needed. Every email has a link to stop.
The Fair Value Range
Fair value under review. Only one analyst covers it, too few to cross-check it; our model's value is 2.02x the price, above our 1.35x limit. We show no fair value, margin of safety or value read built on it until the review clears.
How a fair value is estimated: discounted cash flow (DCF).
Price History & ProjectionsWhere our models see it going: no fair-value estimate yet, range not available, dated to the 2026-11-13 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain WordsChasing silver veins before any cash flows
Picture a junior miner staking claims across Mexico and Canada with nothing yet coming out of the ground. Vizsla Silver sits in exactly that spot, still exploring its Panuco-Copala project while posting zero profit margins and an eleven percent negative return on equity. The numbers alone keep any serious thesis off the table.
We pass because the ethical screen returns insufficient data and the business remains a pure exploration bet in a cyclical sector. Even the thirty five percent gap between current price and modelled fair value offers little comfort when earnings do not exist and commodity cycles can wipe out project economics overnight. Low multiples in this industry often signal peak expectations rather than bargains.
Analysts may eye seven dollars, yet the absence of financial ratios leaves governance and cash burn untested. The cyclical trap here is simple: metal prices rise, projects look cheap, then prices fall and capital gets stranded. Analysis, not advice.
| EPS, trailing | -0.16 |
| Profit margin | 0.0%currently unprofitable |
| Return on equity | -14.0%not currently earning a positive return on equity |
| FCF yield | -3.09% |
| Debt to equity | 0.57moderate, manageable leverage |
| Current ratio | 55.18comfortably covers its short-term bills |
| Beta | 1.57much more volatile than the market |
| Short interest, float | 0.10% |
| 52-week range | 2.88 - 7.19 |
| Market cap | $1.1B |
| Employees | 79 |
Another profit measure, before interest, tax and non-cash costs: EBITDA.
The risks · The things to watch: it's a small-cap, so the share price can swing harder than the market; it already moves more than the market on an average day; its business and earnings are exposed to Canada and to currency swings.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to TradeVZLA trades on NYSE American (the company is based in Canada). As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
Every Entry, As Written
The framework has shifted from markdown to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved up 7.8% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C. Technically it is sitting below its long-term trend line with momentum reading bearish. Over the past year the shares are down 7%. Our forward projection puts the odds of a 10% gain over the next month near 36%. The street (1 analysts) rates it strong buy, with a mean price target of $7.
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 4.1% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C. Technically it is sitting below its long-term trend line with momentum reading bearish. Over the past year the shares are down 7%. Our forward projection puts the odds of a 10% gain over the next month near 36%. The street (1 analysts) rates it strong buy, with a mean price target of $7.
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved up 0.6% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C. Technically it is sitting below its long-term trend line with momentum reading oversold. Over the past year the shares are down 7%. Our forward projection puts the odds of a 10% gain over the next month near 36%. The street (1 analysts) rates it strong buy, with a mean price target of $7.
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 10.2% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C. Technically it is momentum reading neutral. Over the past year the shares are down 7%. Our forward projection puts the odds of a 10% gain over the next month near 36%. The street (1 analysts) rates it strong buy, with a mean price target of $7.
The framework has shifted from distribution to markdown since the last review. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 13.5% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C. Technically it is momentum reading neutral. Over the past year the shares are down 7%. Our forward projection puts the odds of a 10% gain over the next month near 36%. The street (1 analysts) rates it strong buy, with a mean price target of $7.
The framework has shifted from accumulation to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 1.9% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B. Technically it is momentum reading neutral. Over the past year the shares are down 7%. Our forward projection puts the odds of a 10% gain over the next month near 36%. The street (1 analysts) rates it strong buy, with a mean price target of $7.
Our analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 9.5% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B. Technically it is momentum reading neutral. Over the past year the shares are down 7%. Our forward projection puts the odds of a 10% gain over the next month near 36%. The street (1 analysts) rates it strong buy, with a mean price target of $7.
The framework has shifted from markup to accumulation since the last review. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 5.8% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B. Technically it is momentum reading neutral. Over the past year the shares are down 7%. Our forward projection puts the odds of a 10% gain over the next month near 36%. The street (1 analysts) rates it strong buy, with a mean price target of $7.
Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B. Technically it is momentum reading neutral. Over the past year the shares are down 7%. Our forward projection puts the odds of a 10% gain over the next month near 36%. The street (1 analysts) rates it strong buy, with a mean price target of $7.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
- Cronos Group And 2 Other Canadian Penny Stocks To Watch Yahoo Finance · 2d ago
- Canadian Penny Stocks To Watch In November 2026 Yahoo Finance · 4d ago
- Top 3 Canadian Penny Stocks To Watch In November 2026 Yahoo Finance · 5d ago
- 3 Canadian Penny Stocks With ROE Up To 67% Yahoo Finance · 7d ago
- 3 Canadian Penny Stocks With Net Margins Up To 67% Yahoo Finance · 10d ago
Headlines from third-party outlets, linked for reference: not our reporting, not advice.
Screened names in the same industry · explore each on its own page.
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $3.73 | -14.2% | · | $858 | -14.2% |
| 2 months | $3.25 | -1.5% | · | $985 | -1.5% |
| 3 months | $3.88 | -17.5% | · | $825 | -17.5% |
| 6 months | $5.36 | -40.3% | · | $597 | -40.3% |
| 1 year | $3.44 | -7.0% | · | $930 | -7.0% |
| 2 years | $1.69 | +89.4% | · | $1,894 | +89.4% |
| 3 years | $1.19 | +168.9% | · | $2,689 | +168.9% |
Historical returns from market close data. Past performance does not guarantee future results.
This entry now belongs to the ledger. Whatever VZLA does next, these words stay.
Thirteen thousand names carry this page. One desk keeps them honest.
Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.
Join the deskScreening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.